Warning: The NCBI web site requires JavaScript to function. more...
Serial analysis of gene expression of lobular carcinoma in situ identifies down regulation of claudin 4 and overexpression of matrix metalloproteinase 9.
Cao D, Polyak K, Halushka MK, Nassar H, Kouprina N, Iacobuzio-Donahue C, Wu X, Sukumar S, Hicks J, De Marzo A, Argani P.
Breast Cancer Res. 2008;10(5):R91. Epub 2008 Oct 27.
Related citations
Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Green AR, Krivinskas S, Young P, Rakha EA, Paish EC, Powe DG, Ellis IO.
Breast Cancer Res Treat. 2009 Jan;113(1):59-66. Epub 2008 Jan 23.
The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR, Young P, Krivinskas S, Rakha EA, Claire Paish E, Powe DG, Ellis IO.
Histopathology. 2009 Mar;54(4):419-27.
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K.
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. Epub 2001 Jul 31.
Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D, Yoon HS, Perez D, Weeks RJ, Guilford P, Humar B.
J Pathol. 2009 Jun;218(2):265-72.
Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
Giricz O, Reynolds PA, Ramnauth A, Liu C, Wang T, Stead L, Childs G, Rohan T, Shapiro N, Fineberg S, Kenny PA, Loudig O.
J Pathol. 2012 Jan;226(1):108-19. doi: 10.1002/path.2978. Epub 2011 Sep 26.
Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC.
Mol Pathol. 2001 Apr;54(2):91-7.
Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W.
J Pathol. 2006 Apr;208(5):633-42.
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S.
Oncogene. 2003 Apr 3;22(13):2021-33.
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.
Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ.
Br J Cancer. 1997;76(9):1131-3.
[Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S, Penzel R, Schirmacher P, Sinn HP.
Verh Dtsch Ges Pathol. 2007;91:208-13. German.
Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast.
Mastracci TL, Shadeo A, Colby SM, Tuck AB, O'Malley FP, Bull SB, Lam WL, Andrulis IL.
Genes Chromosomes Cancer. 2006 Nov;45(11):1007-17.
MMP13 is potentially a new tumor marker for breast cancer diagnosis.
Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR.
Oncol Rep. 2009 Nov;22(5):1119-27.
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.
Bertucci F, Orsetti B, Nègre V, Finetti P, Rougé C, Ahomadegbe JC, Bibeau F, Mathieu MC, Treilleux I, Jacquemier J, Ursule L, Martinec A, Wang Q, Bénard J, Puisieux A, Birnbaum D, Theillet C.
Oncogene. 2008 Sep 11;27(40):5359-72. Epub 2008 May 19.
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
Breast Cancer Res. 2008;10(5):R87. Epub 2008 Oct 17.
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.
Rahman N, Stone JG, Coleman G, Gusterson B, Seal S, Marossy A, Lakhani SR, Ward A, Nash A, McKinna A, A'Hern R, Stratton MR, Houlston RS.
Br J Cancer. 2000 Feb;82(3):568-70.
Loss of chromosome 16q in lobular carcinoma in situ.
Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung BM, Waldman FM.
Hum Pathol. 2001 Mar;32(3):292-6.
Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP.
Breast Cancer Res Treat. 2008 Feb;107(3):331-5. Epub 2007 Mar 23.
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD.
Gynecol Oncol. 2006 Nov;103(2):405-16. Epub 2006 May 24.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on